Clinical Trial Detail

NCT ID NCT03133221
Title 1630GCC: Zydelig Maintenance in B-Cell Non-Hodgkin's Lymphoma After Autologous Stem Cell Transplantation
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Maryland
Indications

B-cell lymphoma

CLL/SLL

chronic lymphocytic leukemia

marginal zone B-cell lymphoma

non-Hodgkin lymphoma

lymphoplasmacytic lymphoma

follicular lymphoma

Therapies

Idelalisib

Age Groups: adult senior

No variant requirements are available.